Inventor
Bryan A. Frieman
Inventor
La Jolla, CA, US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes20%
A61JContainers specially adapted for medical or pharmaceutical purposes6%
Y02ATechnologies for adaptation to climate change6%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
11,066,417Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators202110,758,534Modulators of cystic fibrosis transmembrane conductance regulator202010,738,030Modulators of cystic fibrosis transmembrane conductance regulator202010,570,115Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator202010,385,070Chroman-spirocyclic piperidine amides as modulators of ion channels201910,258,624Modulators of cystic fibrosis transmembrane conductance regulator201910,233,191Fused piperidine amides as modulators of ion channels20199,782,408'Modulators of cystic fibrosis transmembrane conductance regulator'20179,403,839'Pyran-spirocyclic piperidine amides as modulators of ion channels'20169,365,588'Benzoxazines as modulators of ion channels'20169,199,993'8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists'20159,181,273'Morpholine-spirocyclic piperidine amides as modulators of ion channels'20158,828,996'Morpholine-spirocyclic piperidine amides as modulators of ion channels'20148,802,698'8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists'20148,598,164'Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels'20138,481,563'8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists'20137,902,220'8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2014Based in San Diego, CA, US· patent location history
2013–2021Patents assigned to VERTEX PHARMA (13)· patent assignee history
2013–2019Patents assigned to ARUMUGAM VIJAYALAKSMI (4)· patent assignee history
2013–2019Patents assigned to FRIEMAN BRYAN A (4)· patent assignee history
2013–2019Patents assigned to KALLEL EDWARD ADAM (4)· patent assignee history
2013–2019Patents assigned to MILLER MARK THOMAS (4)· patent assignee history
2014–2021Based in La Jolla, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 13 | 2013–2021 |
| ARUMUGAM VIJAYALAKSMI | 4 | 2013–2019 |
| FRIEMAN BRYAN Aself | 4 | 2013–2019 |
| KALLEL EDWARD ADAM | 4 | 2013–2019 |
| MILLER MARK THOMAS | 4 | 2013–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| La Jolla, California, US | 13 | 2014–2021 |
| San Diego, California, US | 4 | 2011–2014 |